NYSEAMERICAN:NNVCNanoViricides Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NanoViricides Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $7.41 -0.17 (-2.24 %) (As of 07/13/2020 04:00 PM ET) Add Compare Share Today's Range$7.31Now: $7.41▼$7.8550-Day Range N/A52-Week Range$1.27Now: $7.41▼$19.20Volume800,292 shsAverage Volume2.79 million shsMarket Capitalization$67.23 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs, such as injectable and oral anti-influenza nanoviricide drug for H7N9, Bird Flu H5N1, other Highly Pathogenic Influenzas, Epidemic Influenzas, and Seasonal Influenzas; DengueCide, an anti-dengue nanoviricide which is in pre-clinical development; and HIVCide, an anti-human immunodeficiency virus drug candidate. It is also developing HerpeCide, a skin cream for the treatment of cold sores and genital herpes virus infections; and eye drops against viral infections of the external eye, as well as involved in the other research programs against Rabies virus, Ebola, and Marburg viruses. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for NanoViricides. Previous Next 2.1 Community Rank Outperform VotesNanoViricides has received 72 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNanoViricides has received 99 “underperform” votes. (Add your “underperform” vote.)Community SentimentNanoViricides has received 57.89% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about NanoViricides and other stocks. Vote “Outperform” if you believe NNVC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NNVC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNanoViricides does not currently pay a dividend.Dividend GrowthNanoViricides does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NanoViricides insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.42 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:NNVC Previous SymbolNYSEMKT:NNVC CUSIPN/A CIK1379006 Webwww.nanoviricides.com Phone+1-203-9376137Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees7 Outstanding Shares9,073,000Market Cap$67.23 million Next Earnings Date8/28/2020 (Estimated) OptionableOptionable AMEX:NNVC Rates by TradingView Receive NNVC News and Ratings via Email Sign-up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. NanoViricides (NYSEAMERICAN:NNVC) Frequently Asked Questions When is NanoViricides' next earnings date? NanoViricides is scheduled to release its next quarterly earnings announcement on Friday, August 28th 2020. View our earnings forecast for NanoViricides. How were NanoViricides' earnings last quarter? NanoViricides Inc (NYSEAMERICAN:NNVC) announced its quarterly earnings results on Tuesday, February, 19th. The company reported ($0.68) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by $0.08. View NanoViricides' earnings history. When did NanoViricides' stock split? How did NanoViricides' stock split work? NanoViricides shares reverse split on Tuesday, September 24th 2019. The 1-20 reverse split was announced on Thursday, September 12th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 23rd 2019. An investor that had 100 shares of NanoViricides stock prior to the reverse split would have 5 shares after the split. Has NanoViricides been receiving favorable news coverage? Media coverage about NNVC stock has trended very negative recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. NanoViricides earned a coverage optimism score of -3.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about NanoViricides. Are investors shorting NanoViricides? NanoViricides saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 259,600 shares, a decrease of 14.5% from the June 15th total of 303,800 shares. Based on an average daily trading volume, of 856,500 shares, the short-interest ratio is presently 0.3 days. Currently, 3.3% of the shares of the stock are sold short. View NanoViricides' Current Options Chain. Who are some of NanoViricides' key competitors? Some companies that are related to NanoViricides include Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Allergy Therapeutics (AGY), Trilogy International Partners (TRL), Recce Pharmaceuticals (RCE), Futura Medical (FUM), Vita Life Sciences (VLS), Pharmaxis (PXS), Antisense Therapeutics (ANP), China Pharma (CPHI), Avivagen (VIV), Sareum (SAR), Patrys (PAB), Cathay International (CTI) and N4 Pharma (N4P). View all competitors. What other stocks do shareholders of NanoViricides own? Based on aggregate information from My MarketBeat watchlists, some companies that other NanoViricides investors own include Cytosorbents (CTSO), Rekor Systems (REKR), Micron Technology (MU), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Domino's Pizza (DPZ), AbbVie (ABBV), Novavax (NVAX), Vaxart (VXRT) and NVIDIA (NVDA). Who are NanoViricides' key executives? NanoViricides' management team includes the following people: Dr. Anil R. Diwan, Chairman, Pres & Sec. (Age 60)Ms. Meeta R. Vyas SB, MBA, Chief Financial Officer (Age 60)Dr. Eugene Seymour, Chief Exec. Officer Emeritus (Age 78)Dr. Randall W. Barton Ph.D., Chief Scientific Officer & Chief Regulatory Officer (Age 72)Dr. Irach B. Taraporewala, Consultant & Director (Age 63) What is NanoViricides' stock symbol? NanoViricides trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NNVC." How do I buy shares of NanoViricides? Shares of NNVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is NanoViricides' stock price today? One share of NNVC stock can currently be purchased for approximately $7.41. How big of a company is NanoViricides? NanoViricides has a market capitalization of $67.23 million. NanoViricides employs 7 workers across the globe. What is NanoViricides' official website? The official website for NanoViricides is www.nanoviricides.com. How can I contact NanoViricides? NanoViricides' mailing address is 1 Controls Dr, SHELTON, CT 06484-6153, United States. The company can be reached via phone at +1-203-9376137. This page was last updated on 7/14/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
